171 related articles for article (PubMed ID: 33399072)
1. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.
Lee RJ; Wysocki O; Bhogal T; Shotton R; Tivey A; Angelakas A; Aung T; Banfill K; Baxter M; Boyce H; Brearton G; Copson E; Dickens E; Eastlake L; Gomes F; Hague C; Harrison M; Horsley L; Huddar P; Hudson Z; Khan S; Khan UT; Maynard A; McKenzie H; Palmer D; Robinson T; Rowe M; Thomas A; Tweedy J; Sheehan R; Stockdale A; Weaver J; Williams S; Wilson C; Zhou C; Dive C; Cooksley T; Palmieri C; Freitas A; Armstrong AC
ESMO Open; 2021 Feb; 6(1):100005. PubMed ID: 33399072
[TBL] [Abstract][Full Text] [Related]
2. Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.
Iftikhar R; Kamran SM; Mirza ZE; Naseem A; Ali Shah SA; Riaz S; Fazal I; Alamgir W; Saeed F; Saleem S; Ali RS; Chaudhry QUN
J Ayub Med Coll Abbottabad; 2021; 33(3):416-424. PubMed ID: 34487649
[TBL] [Abstract][Full Text] [Related]
3. Routine laboratory testing to determine if a patient has COVID-19.
Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
[No Abstract] [Full Text] [Related]
5. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.
Jimeno S; Ventura PS; Castellano JM; García-Adasme SI; Miranda M; Touza P; Lllana I; López-Escobar A
Eur J Clin Invest; 2021 Jan; 51(1):e13404. PubMed ID: 32918295
[TBL] [Abstract][Full Text] [Related]
6. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients.
Kiani A; Roesch R; Wendtner CM; Kullmann F; Kubin T; Südhoff T; Augustin M; Schaich M; Müller-Naendrup C; Illerhaus G; Hartmann F; Hebart H; Seggewiss-Bernhardt R; Bentz M; Späth-Schwalbe E; Reimer P; Kaiser U; Kapp M; Graeven U; Chemnitz JM; Baesecke J; Lambertz H; Naumann R
Cancer Med; 2021 Jul; 10(13):4424-4436. PubMed ID: 34121360
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Study of Clinical Features of COVID-19 in Inpatients and Their Association with Disease Severity.
Wang H; Xing Y; Yao X; Li Y; Huang J; Tang J; Zhu S; Zhang Y; Xiao J
Med Sci Monit; 2020 Dec; 26():e927674. PubMed ID: 33342993
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
11. Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management.
Marté JL; Toney NJ; Cordes L; Schlom J; Donahue RN; Gulley JL
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33219091
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting mortality in geriatric patients hospitalized with COVID-19.
Bağ Soytaş R; Ünal D; Arman P; Suzan V; Emiroğlu Gedik T; Can G; Korkmazer B; Karaali R; Börekçi Ş; Kuşkucu MA; Yavuzer H; Suna Erdinçler D; Döventaş A
Turk J Med Sci; 2021 Apr; 51(2):454-463. PubMed ID: 33315348
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
15. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE).
Castelo-Branco L; Tsourti Z; Gennatas S; Rogado J; Sekacheva M; Viñal D; Lee R; Croitoru A; Vitorino M; Khallaf S; Šušnjar S; Soewoto W; Cardeña A; Djerouni M; Rossi M; Alonso-Gordoa T; Ngelangel C; Whisenant JG; Choueiri TK; Dimopoulou G; Pradervand S; Arnold D; Harrington K; Michielin O; Dafni U; Pentheroudakis G; Peters S; Romano E
ESMO Open; 2022 Jun; 7(3):100499. PubMed ID: 35644101
[TBL] [Abstract][Full Text] [Related]
19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study.
Gessler N; Gunawardene MA; Wohlmuth P; Arnold D; Behr J; Gloeckner C; Herrlinger K; Hoelting T; Pape UF; Schreiber R; Stang A; Wesseler C; Willems S; Arms C; Herborn CU
PLoS One; 2021; 16(6):e0252867. PubMed ID: 34138888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
